OMAR GALARRAGA

Summary

Country: Mexico

Publications

  1. pmc An instrumental variables evaluation of the effect of antidepressant use on employment among HIV-infected women using antiretroviral therapy in the United States: 1996-2004
    OMAR GALARRAGA
    Division of Health Economics, Mexican School of Public Health, National Institute of Public Health INSP, Cuernavaca, Mexico
    Health Econ 19:173-88. 2010
  2. pmc HIV prevention cost-effectiveness: a systematic review
    OMAR GALARRAGA
    Center for Evaluation Research and Surveys, Mexican School of Public Health National Institute of Public Health INSP, Av Universidad 655, Cuernavaca, Mexico CP 62508
    BMC Public Health 9:S5. 2009
  3. pmc Heterogeneous impact of the "Seguro Popular" program on the utilization of obstetrical services in Mexico, 2001-2006: a multinomial probit model with a discrete endogenous variable
    Sandra G Sosa-Rubí
    Center for Evaluation Research and Surveys, Division of Health Economics, National Institute of Public Health Instituto Nacional de Salud Pública, Cuernavaca, Morelos 62508, Mexico
    J Health Econ 28:20-34. 2009
  4. ncbi request reprint Costs of interventions for AIDS orphans and vulnerable children
    Yared Santa-Ana-Téllez
    Center for Evaluation Research and Surveys, Division of Health Economics, National Institute of Public Health, Cuernavaca, Mexico
    Trop Med Int Health 16:1417-26. 2011
  5. ncbi request reprint Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007-2008
    OMAR GALARRAGA
    Center Evaluation Research and Surveys, National Institute of Public Health INSP, Cuernavaca, Mexico
    AIDS 21:S97-103. 2007
  6. pmc Health insurance for the poor: impact on catastrophic and out-of-pocket health expenditures in Mexico
    OMAR GALARRAGA
    Health Economics Unit, Center for Evaluation and Survey Research, Mexican School of Public Health, National Institute of Public Health INSP, Av Universidad 655, Cuernavaca 62508, Mexico
    Eur J Health Econ 11:437-47. 2010
  7. pmc Stakeholders' opinions and expectations of the Global Fund and their potential economic implications
    OMAR GALARRAGA
    Center for Evaluation Research and Surveys, National Institute of Public Health INSP Mexican School of Public Health, Cuernavaca, Mexico
    AIDS 22:S7-S15. 2008
  8. pmc Diabetes treatment and control: the effect of public health insurance for the poor in Mexico
    Sandra G Sosa-Rubí
    National Institute of Public Health, Health Economics Division, Cuernavaca, Mexico
    Bull World Health Organ 87:512-9. 2009
  9. pmc Financing HIV programming: how much should low- and middle-income countries and their donors pay?
    OMAR GALARRAGA
    Department of Health Services, Policy and Practice, Brown University, School of Public Health, Providence, Rhode Island, USA
    PLoS ONE 8:e67565. 2013
  10. ncbi request reprint [Sex education and HIV prevention: an evaluation in Latin America and the Caribbean]
    Lisa M DeMaria
    Instituto Nacional de Salud Publica, Cuernavaca, Mexico
    Rev Panam Salud Publica 26:485-93. 2009

Detail Information

Publications10

  1. pmc An instrumental variables evaluation of the effect of antidepressant use on employment among HIV-infected women using antiretroviral therapy in the United States: 1996-2004
    OMAR GALARRAGA
    Division of Health Economics, Mexican School of Public Health, National Institute of Public Health INSP, Cuernavaca, Mexico
    Health Econ 19:173-88. 2010
    ..Improved efforts to test, diagnose and treat depression among HIV-positive patients may improve not only clinical indicators but also labor market outcomes...
  2. pmc HIV prevention cost-effectiveness: a systematic review
    OMAR GALARRAGA
    Center for Evaluation Research and Surveys, Mexican School of Public Health National Institute of Public Health INSP, Av Universidad 655, Cuernavaca, Mexico CP 62508
    BMC Public Health 9:S5. 2009
    ..This paper identifies, summarizes and critiques the CE literature related to HIV-prevention interventions in low- and middle-income countries during 2005-2008...
  3. pmc Heterogeneous impact of the "Seguro Popular" program on the utilization of obstetrical services in Mexico, 2001-2006: a multinomial probit model with a discrete endogenous variable
    Sandra G Sosa-Rubí
    Center for Evaluation Research and Surveys, Division of Health Economics, National Institute of Public Health Instituto Nacional de Salud Pública, Cuernavaca, Morelos 62508, Mexico
    J Health Econ 28:20-34. 2009
    ..We focused on the effect of household enrollment in SP on pregnant women's access to obstetrical services, an important outcome measure of both maternal and infant health...
  4. ncbi request reprint Costs of interventions for AIDS orphans and vulnerable children
    Yared Santa-Ana-Téllez
    Center for Evaluation Research and Surveys, Division of Health Economics, National Institute of Public Health, Cuernavaca, Mexico
    Trop Med Int Health 16:1417-26. 2011
    ..To review the published and grey literature for information regarding the costs and cost-effectiveness of interventions aimed at improving the welfare of orphans and vulnerable children owing to HIV/AIDS in low- and middle-income countries...
  5. ncbi request reprint Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007-2008
    OMAR GALARRAGA
    Center Evaluation Research and Surveys, National Institute of Public Health INSP, Cuernavaca, Mexico
    AIDS 21:S97-103. 2007
    ..To inform global planning and implementation, we estimate the volume of current and future demand for active pharmaceutical ingredients for first and second-line antiretroviral drugs...
  6. pmc Health insurance for the poor: impact on catastrophic and out-of-pocket health expenditures in Mexico
    OMAR GALARRAGA
    Health Economics Unit, Center for Evaluation and Survey Research, Mexican School of Public Health, National Institute of Public Health INSP, Av Universidad 655, Cuernavaca 62508, Mexico
    Eur J Health Econ 11:437-47. 2010
    ..SP beneficiaries also had lower expenditures on outpatient and medicine expenditures. The selection-corrected protective effect is found not only in the limited experimental dataset, but also at the national level...
  7. pmc Stakeholders' opinions and expectations of the Global Fund and their potential economic implications
    OMAR GALARRAGA
    Center for Evaluation Research and Surveys, National Institute of Public Health INSP Mexican School of Public Health, Cuernavaca, Mexico
    AIDS 22:S7-S15. 2008
    ..To analyse stakeholder opinions and expectations of the Global Fund to Fight AIDS, Tuberculosis, and Malaria, and to discuss their potential economic and financial implications...
  8. pmc Diabetes treatment and control: the effect of public health insurance for the poor in Mexico
    Sandra G Sosa-Rubí
    National Institute of Public Health, Health Economics Division, Cuernavaca, Mexico
    Bull World Health Organ 87:512-9. 2009
    ..To analyse the effect of enrolment in the public health insurance scheme known as Seguro Popular [People's Insurance] on access to health resources, treatment and blood glucose control among poor adults with diabetes in Mexico...
  9. pmc Financing HIV programming: how much should low- and middle-income countries and their donors pay?
    OMAR GALARRAGA
    Department of Health Services, Policy and Practice, Brown University, School of Public Health, Providence, Rhode Island, USA
    PLoS ONE 8:e67565. 2013
    ..5 billion into a surplus of $0.8 billion. Even with imperfect funding and resource-need data, the proposed country classification could help improve coherence and efficiency in domestic and international allocations. ..
  10. ncbi request reprint [Sex education and HIV prevention: an evaluation in Latin America and the Caribbean]
    Lisa M DeMaria
    Instituto Nacional de Salud Publica, Cuernavaca, Mexico
    Rev Panam Salud Publica 26:485-93. 2009
    ....